Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul E Goss

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
American Journal of Clinical Oncology|August 7, 2003
Emerging role of aromatase inhibitors in the adjuvant settingPaul E Goss
Clinical Advances in Hematology & Oncology : H&O|February 14, 2015
Extending endocrine therapy in women with hormone receptor-positive breast cancerPaul E Goss
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Breast cancer prevention--clinical trials strategies involving aromatase inhibitorsPaul E Goss
Breast Cancer Research and Treatment|September 12, 2008
Extending the benefits of adjuvant therapy in early HR+ breast cancerPaul E Goss
Seminars in Oncology|February 22, 2005
Changing clinical practice: extending the benefits of adjuvant endocrine therapy in breast cancerPaul E Goss
Seminars in Oncology|May 30, 2006
Preventing relapse beyond 5 years: the MA.17 extended adjuvant trialPaul E Goss
Anti-Cancer Drugs|June 24, 2008
Addressing the future: combination with targeted therapies, adjuvant setting and beyondPaul E Goss
Breast Cancer Research and Treatment|November 21, 2007
Letrozole in the extended adjuvant setting: MA.17Paul E Goss
The Oncologist|November 18, 2006
Lapatinib: current status and future directions in breast cancerBeverly Moy, Paul E Goss
Cancer Journal (Sudbury, Mass.)|July 11, 2007
Breast cancer adjuvant endocrine therapyTessa Cigler, Paul E Goss
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
American Journal of Clinical Oncology|August 7, 2003
Emerging role of aromatase inhibitors in the adjuvant settingPaul E Goss
Clinical Advances in Hematology & Oncology : H&O|February 14, 2015
Extending endocrine therapy in women with hormone receptor-positive breast cancerPaul E Goss
The Journal of Steroid Biochemistry and Molecular Biology|November 19, 2003
Breast cancer prevention--clinical trials strategies involving aromatase inhibitorsPaul E Goss
Breast Cancer Research and Treatment|September 12, 2008
Extending the benefits of adjuvant therapy in early HR+ breast cancerPaul E Goss
Seminars in Oncology|February 22, 2005
Changing clinical practice: extending the benefits of adjuvant endocrine therapy in breast cancerPaul E Goss
Seminars in Oncology|May 30, 2006
Preventing relapse beyond 5 years: the MA.17 extended adjuvant trialPaul E Goss
Anti-Cancer Drugs|June 24, 2008
Addressing the future: combination with targeted therapies, adjuvant setting and beyondPaul E Goss
Breast Cancer Research and Treatment|November 21, 2007
Letrozole in the extended adjuvant setting: MA.17Paul E Goss
The Oncologist|November 18, 2006
Lapatinib: current status and future directions in breast cancerBeverly Moy, Paul E Goss
Cancer Journal (Sudbury, Mass.)|July 11, 2007
Breast cancer adjuvant endocrine therapyTessa Cigler, Paul E Goss
Pageof 16